SCHEMBL7015222

SCHEMBL7015222

CC(=O)Nc1cccc2c1C(=O)N(CC([NH])=O)C2=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 1/20 0.54
▸ MAOA P21397 1/20 0.50
▸ DDB1 Q16531 1/20 0.49
▸ CRBN Q96SW2 1/20 0.49
▸ KDM4E B2RXH2 4/20 0.49
▸ ALDH1A1 P00352 4/20 0.49
▸ HPGD P15428 3/20 0.49
▸ GAA P10253 2/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ MAPT P10636 2/20 0.48
▸ CASP3 P42574 1/20 0.47
▸ KMT2A Q03164 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ PABPC1 P11940 1/20 0.43
▸ RPS6KA2 Q15349 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ CCNE2 O96020 2/20 0.42
▸ CCNE1 P24864 2/20 0.42
▸ CDK2 P24941 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21335854 0.79 AHR (0.52) AHRMAOADDB1CRBNKDM4E
SCHEMBL18669039 0.78 SMN1; SMN2 (0.57) AHRMAOADDB1CRBNKDM4E
SCHEMBL7794720 0.78 AHR (0.51) AHRMAOADDB1CRBNKDM4E
SCHEMBL24182074 0.77 AHR (0.50) AHRMAOADDB1CRBNKDM4E
SCHEMBL18826569 0.77 HPGD (0.71) AHRMAOADDB1CRBNKDM4E
SCHEMBL9133504 0.74 POLB (0.69) KDM4EALDH1A1GAAMAPTKMT2A
SCHEMBL18669229 0.74 AHR (0.47) AHRMAOADDB1CRBNKDM4E
SCHEMBL10913894 0.74 AHR (0.47) AHRMAOADDB1CRBNKDM4E
SCHEMBL6425824 0.74 CA12 (0.68) KDM4EALDH1A1GAAMAPTKMT2A
SCHEMBL18669027 0.73 GRM5 (0.50) AHRKDM4EALDH1A1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1278739-A1 AMINO SUBSTITUTED DIBENZOTHIOPHENE DERIVATIVES FOR THE TREATMENT OF DISORDERS MEDIATED BY THE NP Y5 RECEPTOR AstraZeneca AB (SE) 2003-01-29 — — EP disclosed
WO-2001085714-A1 AMINO SUBSTITUTED DIBENZOTHIOPHENE DERIVATIVES FOR THE TREATMENT OF DISORDERS MEDIATED BY THE NP Y5 RECEPTOR ASTRAZENECA AB (SE) 2001-11-15 — — WO disclosed
Send feedback